Deciphex

Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies

Collaboration Agreement Seeks to engage AI to Transform Non-clinical Pathology Assessments in Drug Discovery and Development   DUBLIN, Ireland, April 23, 2024 – Deciphex, a Dublin-based digital pathology company,has entered into a Collaboration Agreement with Novartis […]

Read more

Deciphex Secures €3.9m Funding to Boost Digital Pathology and AI Services.

25 January 2023. Dublin, Ireland.  Deciphex, a leading provider of pathology software and services, announced today a further €3.9m in funding bringing its full Series B round tally to €15m. The additional investment, led by Seroba […]

Read more

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top